The results from a clinical trial at Washington University on an experimental drug used for slowing disease progress in Alzheimer's patients may also delay onset in people predisposed to the disease who are yet to show symptoms. @ScienceAlert reports:
https://www.sciencealert.com/anti-amyloid-drug-may-delay-alzheimers-symptoms-in-those-at-risk-clinical-trial-finds